[1]
Matić M, Matić A, Gajinov Z, Golušin Z, Prćić S, Jeremić B. Major risk factors for chronic venous disease development in women: is childbirth among them? Women & health. 2019 Nov-Dec:59(10):1118-1127. doi: 10.1080/03630242.2019.1590492. Epub 2019 Mar 24
[PubMed PMID: 30907276]
[2]
Lacroix P, Aboyans V, Preux PM, Houlès MB, Laskar M. Epidemiology of venous insufficiency in an occupational population. International angiology : a journal of the International Union of Angiology. 2003 Jun:22(2):172-6
[PubMed PMID: 12865883]
[3]
Branisteanu DE, Feodor T, Baila S, Mitea IA, Vittos O. Impact of chronic venous disease on quality of life: Results of vein alarm study. Experimental and therapeutic medicine. 2019 Feb:17(2):1091-1096. doi: 10.3892/etm.2018.7054. Epub 2018 Dec 5
[PubMed PMID: 30679979]
Level 2 (mid-level) evidence
[4]
Tisato V, Zauli G, Voltan R, Gianesini S, di Iasio MG, Volpi I, Fiorentini G, Zamboni P, Secchiero P. Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. PloS one. 2012:7(6):e39543. doi: 10.1371/journal.pone.0039543. Epub 2012 Jun 21
[PubMed PMID: 22737245]
[5]
Tisato V,Zamboni P,Menegatti E,Gianesini S,Volpi I,Zauli G,Secchiero P, Endothelial PDGF-BB produced ex vivo correlates with relevant hemodynamic parameters in patients affected by chronic venous disease. Cytokine. 2013 Aug;
[PubMed PMID: 23664275]
[6]
Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW. Cellular and molecular basis of Venous insufficiency. Vascular cell. 2014:6(1):24. doi: 10.1186/s13221-014-0024-5. Epub 2014 Dec 12
[PubMed PMID: 25520775]
[7]
Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. International journal of molecular sciences. 2018 Jun 5:19(6):. doi: 10.3390/ijms19061669. Epub 2018 Jun 5
[PubMed PMID: 29874834]
[8]
Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. Journal of vascular surgery. 1995 Apr:21(4):635-45
[PubMed PMID: 7707568]
Level 3 (low-level) evidence
[9]
Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, Blebea J, Carpentier PH, De Maeseneer M, Gasparis A, Labropoulos N, Marston WA, Rafetto J, Santiago F, Shortell C, Uhl JF, Urbanek T, van Rij A, Eklof B, Gloviczki P, Kistner R, Lawrence P, Moneta G, Padberg F, Perrin M, Wakefield T. The 2020 update of the CEAP classification system and reporting standards. Journal of vascular surgery. Venous and lymphatic disorders. 2020 May:8(3):342-352. doi: 10.1016/j.jvsv.2019.12.075. Epub 2020 Feb 27
[PubMed PMID: 32113854]
[10]
Yamamoto T, Sakata M. Influence of fibers and wavelengths on the mechanism of action of endovenous laser ablation. Journal of vascular surgery. Venous and lymphatic disorders. 2014 Jan:2(1):61-9. doi: 10.1016/j.jvsv.2013.05.009. Epub 2013 Aug 31
[PubMed PMID: 26992971]
[11]
Lawson JA, Gauw SA, van Vlijmen CJ, Pronk P, Gaastra MTW, Tangelder MJ, Mooij MC. Prospective comparative cohort study evaluating incompetent great saphenous vein closure using radiofrequency-powered segmental ablation or 1470-nm endovenous laser ablation with radial-tip fibers (Varico 2 study). Journal of vascular surgery. Venous and lymphatic disorders. 2018 Jan:6(1):31-40. doi: 10.1016/j.jvsv.2017.06.016. Epub 2017 Aug 24
[PubMed PMID: 29248107]
Level 2 (mid-level) evidence
[12]
Shingler S, Robertson L, Boghossian S, Stewart M. Compression stockings for the initial treatment of varicose veins in patients without venous ulceration. The Cochrane database of systematic reviews. 2013 Dec 9:(12):CD008819. doi: 10.1002/14651858.CD008819.pub3. Epub 2013 Dec 9
[PubMed PMID: 24323411]
Level 1 (high-level) evidence
[13]
Nandhra S, Wallace T, El-Sheikha J, Leung C, Carradice D, Chetter I. A Randomised Clinical Trial of Buffered Tumescent Local Anaesthesia During Endothermal Ablation for Superficial Venous Incompetence. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2018 Nov:56(5):699-708. doi: 10.1016/j.ejvs.2018.05.017. Epub 2018 Jun 29
[PubMed PMID: 30392525]
Level 1 (high-level) evidence
[14]
Vuylsteke ME, Klitfod L, Mansilha A. Endovenous ablation. International angiology : a journal of the International Union of Angiology. 2019 Feb:38(1):22-38. doi: 10.23736/S0392-9590.18.04047-6. Epub 2018 Nov 20
[PubMed PMID: 30465420]
[15]
Healy DA, Kimura S, Power D, Elhaj A, Abdeldaim Y, Cross KS, McGreal GT, Burke PE, Moloney T, Manning BJ, Kavanagh EG. A Systematic Review and Meta-analysis of Thrombotic Events Following Endovenous Thermal Ablation of the Great Saphenous Vein. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2018 Sep:56(3):410-424. doi: 10.1016/j.ejvs.2018.05.008. Epub 2018 Jun 9
[PubMed PMID: 29895399]
Level 1 (high-level) evidence
[16]
Dexter D, Kabnick L, Berland T, Jacobowitz G, Lamparello P, Maldonado T, Mussa F, Rockman C, Sadek M, Giammaria LE, Adelman M. Complications of endovenous lasers. Phlebology. 2012 Mar:27 Suppl 1():40-5
[PubMed PMID: 22312066]
[17]
Kheirelseid EAH, Crowe G, Sehgal R, Liakopoulos D, Bela H, Mulkern E, McDonnell C, O'Donohoe M. Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins. Journal of vascular surgery. Venous and lymphatic disorders. 2018 Mar:6(2):256-270. doi: 10.1016/j.jvsv.2017.10.012. Epub 2017 Dec 29
[PubMed PMID: 29292115]
Level 1 (high-level) evidence